EARNING RECAP

Goldman Sachs Group Inc

#GS 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q3 $4.79 est. $4.81 $8.32B est. $8.31B +.31% ($206.46 closing price) $208.24 $198.61 Q3 annualized ROE 9%
Q2 $5.81 est. $4.89 $9.46B est. $8.83B +1.86% ($215.52 closing price) $217.33 $212.55 returned $1.57B of capital to shareholders in Q2
Q1 $5.71 est, $4.89 $8.81B est. $9.04B -3.82% ($199.91 closing price) $205.74 $199.70 sees deposit increasing $10B/ year; CFO says saving $100M/ year using own cash management business
#GS 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $6.04 est. $5.61 $8.08B est. $7.78B +9.54% ($197.08 closing price) $198.15 $185.60 Q4 ROE 12.1% FY18 ROE 13.3%; CEO says plan to share financial targets later this year. Sees $2B legal cost for the 1MDB scandal
Q3 $6.28 est. $5.38 $8.65B est. $8.38B +3.01% ($221.70 closing) $222 $216.30 says YTD earnings per share highest in history; Q3 average ROE 13.1%
Q2 $5.98 est. $4.66 $9.4B est. $8.74B -.18% ($231.02 closing) $233.23 $226.87 Q2 annualized ROE 12.8%; FICC revenue 45% higher than last year. Announced new CEO - Solomon effective Oct.1 as Blankfein retire as Chairman & CEO
Q1 $6.95 est. $5.58 $10.04B est. $8.74B -1.65% ($253.63 closing) $262.25 $252.34 increases dividen to 80c per share, during Q1 it repurchased 3m shares at $264.32 cost $800M
#GS 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $5.60 ex Tax Legislation Vs $4.92 est $7.83B vs $7.61B -1.86% $262 $248.83 Stock popped and faded during trading hours.
Q3 $5.02 vs $4.17 $8.33B vs $7.54B ($236.09 closing) $244.89 $235.19 reports Q3 FICC revenue $1.45B, down 26% y/y
Q2 $3.95 VS $3.39 EST $7.89B VS $7.52B -2.60% ($223.31 closing) $230.36 $222.76 Open and faded throughout the day
Q1 $5.15 vs $5.31 $8.03B Vs $8.45B -4.72% ($215.59 closing) $219.89 $213.18 Gap down opened and faded throughout the day. Company raises dividend to 0.75c from 0.65c per share

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.